These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 1628691)

  • 1. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W; Klinger G; Jäger R; Kasch R; Brandstädt A
    Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ethinyl estradiol following the administration of combination contraceptive preparations].
    Carol W; Klinger G; Jäger R; Kasch R
    Zentralbl Gynakol; 1990; 112(3):135-41. PubMed ID: 2336888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W; al-Yacoub G; Fuhrmeister A
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of contraceptive steroids with reference to long-term administration].
    Carol W; Klinger G; Michels W; Boer J; Pocha C
    Zentralbl Gynakol; 1991; 113(23):1298-303. PubMed ID: 1796663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of physical training on the pharmacokinetics of steroidal contraceptives].
    Klinger G; Seidel E; Carol W; Boer J; Pocha C
    Zentralbl Gynakol; 1991; 113(22):1240-5. PubMed ID: 1755260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
    Abdalla KA; Shabaan MM; Stanczyk FZ
    Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
    Joshi JV; Sankolli GM; Shah RS; Joshi UM
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):192-5. PubMed ID: 3086241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months.
    Dibbelt L; Knuppen R; Kuhnz W; Jütting G
    Arzneimittelforschung; 1992 Sep; 42(9):1146-52. PubMed ID: 1445484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inter- and intra-individual variability of pharmacokinetic parameters for contraceptive steroids].
    Carol W; Klinger G; Jäger R; Kasch R; Michels W
    Zentralbl Gynakol; 1991; 113(13):783-7. PubMed ID: 1927130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
    Stanczyk FZ; Lobo RA; Chiang ST; Woutersz TB
    Contraception; 1990 Jan; 41(1):39-53. PubMed ID: 2105872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
    Song S; Chen JK; He ML; Fotherby K
    Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
    Cawello W; Rosenkranz B; Schmid B; Wierich W
    Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.